
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
Gemma L. Baillie, James G. Horswill, Sharon Anavi‐Goffer, et al.
Molecular Pharmacology (2012) Vol. 83, Iss. 2, pp. 322-338
Open Access | Times Cited: 110
Gemma L. Baillie, James G. Horswill, Sharon Anavi‐Goffer, et al.
Molecular Pharmacology (2012) Vol. 83, Iss. 2, pp. 322-338
Open Access | Times Cited: 110
Showing 1-25 of 110 citing articles:
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 20, pp. 4790-4805
Open Access | Times Cited: 862
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 20, pp. 4790-4805
Open Access | Times Cited: 862
G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 419
CB 1 and CB 2 Receptor Pharmacology
Allyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Allyn C. Howlett, Mary E. Abood
Advances in pharmacology (2017), pp. 169-206
Open Access | Times Cited: 294
Pregnenolone Can Protect the Brain from Cannabis Intoxication
Monique Vallée, S. Vitiello, Luigi Bellocchio, et al.
Science (2014) Vol. 343, Iss. 6166, pp. 94-98
Open Access | Times Cited: 275
Monique Vallée, S. Vitiello, Luigi Bellocchio, et al.
Science (2014) Vol. 343, Iss. 6166, pp. 94-98
Open Access | Times Cited: 275
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors
Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, et al.
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1455-1469
Open Access | Times Cited: 270
Mylyne Tham, Orhan Yılmaz, Mariam Alaverdashvili, et al.
British Journal of Pharmacology (2018) Vol. 176, Iss. 10, pp. 1455-1469
Open Access | Times Cited: 270
Cannabinoid CB1and CB2Receptor Signaling and Bias
Mikkel Søes Ibsen, Mark Connor, Michelle Glass
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 48-60
Open Access | Times Cited: 195
Mikkel Søes Ibsen, Mark Connor, Michelle Glass
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 48-60
Open Access | Times Cited: 195
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij, Samantha J. Broyd, Lisa‐Marie Greenwood, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 17-35
Open Access | Times Cited: 161
Nadia Solowij, Samantha J. Broyd, Lisa‐Marie Greenwood, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 17-35
Open Access | Times Cited: 161
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Zhenhua Shao, Wei Yan, Karen Chapman, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 12, pp. 1199-1205
Closed Access | Times Cited: 153
Zhenhua Shao, Wei Yan, Karen Chapman, et al.
Nature Chemical Biology (2019) Vol. 15, Iss. 12, pp. 1199-1205
Closed Access | Times Cited: 153
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 144
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 144
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 136
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 136
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Bogna M. Ignatowska‐Jankowska, Gemma L. Baillie, Steven G. Kinsey, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 13, pp. 2948-2959
Open Access | Times Cited: 151
Bogna M. Ignatowska‐Jankowska, Gemma L. Baillie, Steven G. Kinsey, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 13, pp. 2948-2959
Open Access | Times Cited: 151
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Distinct Roles of β-Arrestin 1 and β-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)
Kwang H. Ahn, Mariam M. Mahmoud, Joong‐Youn Shim, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 14, pp. 9790-9800
Open Access | Times Cited: 128
Kwang H. Ahn, Mariam M. Mahmoud, Joong‐Youn Shim, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 14, pp. 9790-9800
Open Access | Times Cited: 128
Biased Agonism and Biased Allosteric Modulation at the CB1Cannabinoid Receptor
Elham Khajehali, Daniel T. Malone, Michelle Glass, et al.
Molecular Pharmacology (2015) Vol. 88, Iss. 2, pp. 368-379
Open Access | Times Cited: 128
Elham Khajehali, Daniel T. Malone, Michelle Glass, et al.
Molecular Pharmacology (2015) Vol. 88, Iss. 2, pp. 368-379
Open Access | Times Cited: 128
The Endocannabinoid Signaling System in the CNS
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111
Cecilia J. Hillard
International review of neurobiology (2015), pp. 1-47
Open Access | Times Cited: 111
Real‐time characterization of cannabinoid receptor 1 (CB 1) allosteric modulators reveals novel mechanism of action
Erin E. Cawston, William Redmond, Courtney M Breen, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 4, pp. 893-907
Open Access | Times Cited: 108
Erin E. Cawston, William Redmond, Courtney M Breen, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 4, pp. 893-907
Open Access | Times Cited: 108
New Insights in Cannabinoid Receptor Structure and Signaling
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Lingyan Ye, Zheng Cao, Weiwei Wang, et al.
Current Molecular Pharmacology (2019) Vol. 12, Iss. 3, pp. 239-248
Open Access | Times Cited: 105
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 441-474
Open Access | Times Cited: 89
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 441-474
Open Access | Times Cited: 89
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review
Paula Morales, Pilar Goya, Nadine Jagerovic, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 22-30
Open Access | Times Cited: 84
Paula Morales, Pilar Goya, Nadine Jagerovic, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 22-30
Open Access | Times Cited: 84
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Srikrishnan Mallipeddi, David R. Janero, Nikolai Zvonok, et al.
Biochemical Pharmacology (2016) Vol. 128, pp. 1-11
Open Access | Times Cited: 81
Srikrishnan Mallipeddi, David R. Janero, Nikolai Zvonok, et al.
Biochemical Pharmacology (2016) Vol. 128, pp. 1-11
Open Access | Times Cited: 81
The Multiple Waves of Cannabinoid 1 Receptor Signaling
Carlos Nogueras‐Ortiz, Guillermo A. Yudowski
Molecular Pharmacology (2016) Vol. 90, Iss. 5, pp. 620-626
Open Access | Times Cited: 77
Carlos Nogueras‐Ortiz, Guillermo A. Yudowski
Molecular Pharmacology (2016) Vol. 90, Iss. 5, pp. 620-626
Open Access | Times Cited: 77